Sanofi India enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Dec 2025FY25Dec 2024FY24Dec 2023FY23Dec 2022FY22 and earlierAlpha Plus
6,882————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
2632632843931,005
6,619————
−263−263−284−393−1,005
₹2,877.70————
7497498611,0161,276
3.63×————
12.99×————
13.98×————
16.04×————
Reference items — trailing FY values
1,8221,8372,0132,8512,770
510491491804704
473454454764663
—438462231399
413413425197377
—412425196376
—25.736.434.322.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SANOFI₹2,992.00

Sanofi India Limited

· Pharma & Health
₹ CrorePeersSENORESINNOVACAPPGHLMOREPENLABIOLCPSANOFICONRFDCORCHPHARMAMcap ₹6,882 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/12/2022
FY24
31/12/2023
FY25
31/12/2024
FY26
31/12/2025
Current/LTM
TTM · last close
Market Capitalization————6,881.6
- Cash, Equiv & ST Investments1,004.9392.9283.8262.9262.9
Enterprise Value————6,618.7
Net Debt (memo)-1,004.9-392.9-283.8-262.9-262.9
EV per Share————2,877.70
Total Capital1,275.81,015.5860.6749.2749.2
EV/Sales————3.63
EV/EBITDA————12.99
EV/EBIT————13.98
EV/Free Cash Flow————16.04
Reference Items — Trailing FY Values
Sales2,770.12,851.12,013.21,837.41,821.5
EBITDA704.4804.0490.8491.3509.6
EBIT662.5764.4454.1454.0473.4
Operating Cash Flow398.7230.8461.7438.3—
Free Cash Flow376.5196.5425.3412.6412.6
FCFF (free cash flow to the firm)376.0196.0424.9412.2—
Capital Expenditure22.234.336.425.7—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.